Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Yunshan Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4873-054X; OpenAlex author ID A5100613240. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2019: 1 paper · 2020: 3 papers · 2021: 4 papers · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 10

  1. The interaction between UBR7 and PRMT5 drives PDAC resistance to gemcitabine by regulating glycolysis and immune microenvironment. Co-author DOI 10.1038/s41419-024-07145-z↗
  2. Highly Sensitive Exosome Detection for Early Diagnosis of Pancreatic Cancer Using Immunoassay Based on Hierarchical Surface-Enhanced Raman Scattering Substrate. Co-author DOI 10.1002/smtd.202200154↗
  3. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more. Last author DOI 10.1016/j.biopha.2021.111798↗
  4. Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer. Co-author DOI 10.1016/j.omtn.2021.06.001↗
  5. LECT 2 Antagonizes FOXM1 Signaling via Inhibiting MET to Retard PDAC Progression. Co-author DOI 10.3389/fcell.2021.661122↗
  6. The Function of cGAS-STING Pathway in Treatment of Pancreatic Cancer. Co-author DOI 10.3389/fimmu.2021.781032↗
  7. Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance. Co-author DOI 10.1016/j.pan.2019.11.006↗
  8. Holliday junction recognition protein promotes pancreatic cancer growth and metastasis via modulation of the MDM2/p53 signaling. Co-author DOI 10.1038/s41419-020-2595-9↗
  9. The involvement of exosomes in the diagnosis and treatment of pancreatic cancer. Co-author DOI 10.1186/s12943-020-01245-y↗
  10. Obesity and pancreatic cancer: An update of epidemiological evidence and molecular mechanisms. Co-author DOI 10.1016/j.pan.2019.08.008↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chuanxin Wang · 4 shared papers, 2020–2022 · strength 0.54
  2. Abakundana Nsenga Ariston Gabriel · 3 shared papers, 2020–2021 · strength 0.39
  3. Maoxiao Feng · 2 shared papers, 2021–2024 · strength 0.39
  4. Xin Li · 2 shared papers, 2020–2021 · strength 0.25
  5. Chenjing Wang · 2 shared papers, 2020–2021 · strength 0.25
  6. Lei Bi · 1 shared paper, 2024 · strength 0.22
  7. Sanyuan Hu · 2 shared papers, 2019–2021 · strength 0.21
  8. Bin Zhou · 2 shared papers, 2019–2021 · strength 0.21
  9. Xiaodong Hao · 1 shared paper, 2021 · strength 0.17
  10. Ghazal Mohseni · 1 shared paper, 2021 · strength 0.16
  11. Juan Li · 1 shared paper, 2021 · strength 0.16
  12. J J Li · 1 shared paper, 2022 · strength 0.15
  13. Yu J Cao · 1 shared paper, 2021 · strength 0.14
  14. Jian Yang · 1 shared paper, 2021 · strength 0.12
  15. Bingyuan Zhang · 1 shared paper, 2021 · strength 0.12
  16. Yongzheng Li · 1 shared paper, 2021 · strength 0.12
  17. Zhaowei Sun · 1 shared paper, 2021 · strength 0.12
  18. Zhiyao Fan · 1 shared paper, 2021 · strength 0.12
  19. Hanxiang Zhan · 1 shared paper, 2021 · strength 0.12
  20. Fang Wang · 1 shared paper, 2020 · strength 0.11
  21. Yu Cao · 1 shared paper, 2020 · strength 0.11
  22. Hanxiang Zhan · 1 shared paper, 2019 · strength 0.10
  23. Jianwei Xu · 1 shared paper, 2019 · strength 0.10
  24. Han Liu · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.